A limiting-dilution analysis technique was developed which enumerates human T cells with the capacity to secrete T-cell growth factors such as interleukin 2 after contact with herpes simplex virus type 1 (HSV-1) or cytomegalovirus (CMV) antigens (operationally defined as virus-reactive helper T cells [HTL]). By using this limiting-dilution analysis technique, the peripheral blood of HSV-seropositive individuals was analyzed for the frequency of HSV antigen-reactive HTL and for the ability either to proliferate or to secrete detectable T-cell growth factors in conventional HSV antigen-stimulated lymphocyte cultures. We found that the magnitudes of the latter two responses did not correlate directly with the frequency estimates of HSV antigen-reactive HTL.
Herpes group viruses can cause severe, life-threatening complications in individuals whose viral immunity is genetically (44) or pharmacologically (22) compromised. Clinical assessment of immunity to herpes simplex virus (HSV) usually involves a serologic analysis of peripheral blood for the presence of HSV-reactive antibodies. In general, the presence of such antibodies (i.e., a seropositive response) is considered to be evidence of existing antiviral immunity. In contrast, a seronegative response is generally considered to indicate an individual who is susceptible to a viral infection due to an apparent lack of protective antiviral immunity. Although specific antibodies can protect against a subsequent viral challenge (1), humoral immunity (serologic status) does not reflect the ability to recover from established infections (11) or to protect against reactivation of latent herpesviruses (28) . Furthermore, clinical observations have implicated cell-mediated immunity as an essential component for recovery from viral infections caused by herpes group viruses (14) . The extent to which viral antigen-reactive cell-mediated immunity correlates with serologic status is even more uncertain (39, 46) .
T cells appear to play a major role in the resolution of viral infection. In vitro studies have shown that (i) human peripheral blood mononuclear cells (PBMC) from sensitized individuals can be induced to proliferate after exposure to viral antigen (19, 34, 39, 46) , (ii) viral antigen-specific cytolytic T lymphocytes can be generated from sensitized PBMC (32, 36) and have been cloned (45) , and (iii) PBMC from sensitized individuals secrete lymphokines, including interleukin 2 (IL-2), after contact with viral antigens (8, 15) . Thus, in vitro evidence suggests that the cellular immune responses to these viruses involve both helper T lymphocytes (HTL) and cytotoxic T lymphocytes (12, 17) .
In most of these studies, assessment of T-lymphocyte reactivity has been nonquantitative, due primarily to the technical design of the available assays. For example, detection of proliferation, lymphokine secretion, or cytotoxic activity in mixed lymphocyte-virus cultures demonstrates the presence of viral antigen-reactive lymphocytes but provides little information regarding the size or efficiency of the responding T-cell population. Furthermore, active T lymphocytes are not detectable in such cultures if they did not constitute a relatively large proportion of the responding population (31) , and their detection may be influenced by suppressive multicellular interactions (23) . An assay of Tlymphocyte behavior which would circumvent these problems is limiting-dilution analysis (LDA). LDA can detect T lymphocytes with defined antigen specificity and functional capacity even when they are present in very small numbers. In addition, some (20, 23, 24) but not all (40) LDAs have been shown to be insensitive to regulatory mechanisms functioning in other culture systems. Furthermore, the LDA is a quantitative immunologic technique that monitors T-cell numbers and thus allows analysis of changes in the sizes of specific T-lymphocyte subpopulations.
Although LDAs of antigen-specific cytotoxic T lymphocytes (5, 30) and HTL (26, 29) Viral antigens. Purified HSV-1 was prepared by using the methods described by Gehrz et al. (13) and Spear and Roizman (38) . Briefly, human foreskin fibroblast cells were infected with stock HSV-1 lysate (109 PFU/ml) at a multiplicity of infection of 2 PFU per cell and were incubated at 37°C until the cytopathic effect involved 90% of the monolayer. Supernatants from infected cells and the cytoplasmic extracts obtained after disruption of infected cells in a Dounce homogenizer were pooled and clarified by centrifugation at 7,500 x g for 20 min. The virus was sedimented from the clarified medium and concentrated by centrifugation at 131,000 x g for 1 h and then purified by rate zonal centrifugation in a 10 to 50% sucrose gradient at 131,000 x g for 1 h. The opalescent band containing the virions was aspirated and stored at -80°C until used. Control (mock) antigen was prepared in the same manner by using uninfected human foreskin fibroblast cultures. The purified HSV-1 antigen and mock antigen preparations contained 850 and 600 lig of protein per ml, respectively, as determined by the method of Lowry et al. (20) . All viral antigen preparations (purified virus and cell lysates) were inactivated by exposure to UV irradiation from two G15T8 germicidal bulbs (General Electric Co., Waterford, N.Y.) for 4 min at a distance of 5 cm. No plaques were detected on a human foreskin fibroblast monolayer after inactivation. Viral antigens were then titrated to determine the optimal dilution for induction of lymphocyte proliferation. Viral 200 ,ul of complete medium in U-bottomed microdilution wells. The cultures were incubated at 37°C in 5% C02 for 6 days, which was the optimum period as determined by preliminary kinetic studies. After an 8-h terminal pulse with [3H]thymidine (1 ,uCi per well), the cells were harvested and counted, and the results from triplicate wells were expressed as mean counts per minute.
Assay for human TCGF production. TCGF production was detected in virus-stimulated cultures using TCGF-dependent murine CTLL-20 cells. This cell line is known to respond to human IL-2, but, like other lymphokine-dependent cell lines, its pattern of lymphokine reactivity is not completely understood. We presume that all lymphokines which are mitogenic for CTLL-20 cells are TCGF. Hence, we defined the lymphokine(s) detected in this study as TCGF without attempting to document the production of a particular growth factor, such as IL-2.
The CTLL-20 cells were maintained by weekly transfer of 104 viable cells to upright 25-cm2 (Corning T4160) tissue culture flasks containing 10 ml of Dulbecco modified Eagle medium (GIBCO) supplemented with 5 x 10-5 M 2-mercaptoethanol, additional amino acids (35) , 2% (vol/vol) fetal calf serum, and 5% supernatant from rat concanavalin A-induced splenocytes. Mixed leukocyte-virus cultures were set up in U-bottomed microdilution plates as indicated above, except in 100 pl of medium. After 24 h of incubation at 37°C in 5% C02, the plates were gamma irradiated (2,500 R) and 100 ,ul of Dulbecco modified Eagle medium containing 5% human serum and 103 CTLL-20 cells was added to each well of the irradiated plates, which were then reincubated for 24 dilution microculture conditions were adapted from a method of TCGF detection described previously (7, 8 
RESULTS
Description of the analytic system. We have described elsewhere (29) a limiting-dilution culture system that enables detection and quantitation of alloantigen-reactive HTL. We have adapted this protocol to allow detection of HTL (defined operationally by the capacity to secrete TCGF regardless of cell surface phenotype) that are reactive with specific viral antigens. The general design of the protocol was as follows. Dilutions of responder cells were cultured with viral antigens for a period sufficient to allow initial T-cell activation events to occur. The responder cells were then gamma irradiated to impair their ability to proliferate (9) while allowing them to continue lymphokine secretion (7, 43 These theoretical considerations are supported by the data in Fig. 1, for which , and a chi-square evaluation of probability (P). The frequency of HSV-reactive PBMC in the individual under study was 1 cell per 12,390 PBMC, whereas the frequency of cells in the same PBMC population that could respond to the mock viral antigen was 1 cell per 536,407 PBMC (Fig. 3) .
We next determined the relationship between the frequency of HSV antigen-reactive HTL in a PBMC population and the ability of that PBMC population to proliferate or secrete detectable TCGF in conventional lymphocyte cultures. For these experiments, PBMC from different HSVseropositive individuals were concurrently evaluated for HSV-reactive HTL frequency by LDA and for HSV antigeninduced proliferation in conventional lymphocyte cultures. Some populations were also evaluated for HSV antigeninduced TCGF production in conventional lymphocyte cultures as detected by a procedure described elsewhere (8) .
Contact of PBMC with HSV antigen induced significant TCGF production and prominent proliferative responses in conventional lymphocyte cultures (Table 1) It has been reported that PBMC from seronegative individuals fail to proliferate when incubated in conventional lymphocyte cultures with appropriate viral antigens (3, 46) . Our previous studies have shown that PBMC from HSVseronegative individuals which fail to proliferate when stimulated in vitro with HSV antigen also fail to produce detectable levels of TCGF in high-density lymphocyte cultures (8 detectable, HSV antigen-reactive HTL but not CMV antigen-reactive HTL. The reciprocal relationship should exist for individuals who are HSV seronegative and CMV seropositive. Experimental data confirming these relationships would also demonstrate the viral antigen specificity of the HTL that are detected by LDA.
To verify serologic status, sera from a number of healthy individuals were analyzed for HSV-reactive and CMVreactive antibodies by using an enzyme-linked immunosorbent assay method. The PBMC from some of these individuals were then tested by LDA for frequency of HSV-reactive and CMV-reactive HTL. The optimal concentrations of CMV antigen (0.9 ,ug of protein per ml) and HSV antigen (0.8 ,ug of protein per ml) used in the limiting-dilution microcultures were determined in advance in separate experiments (data not shown). The PBMC were also tested for frequency of alloantigen-reactive HTL by using a protocol described in a separate communication (29) .
The results of these experiments are shown in Table 3 . In general, we observed that PBMC from individuals who were seropositive for either virus contained relatively high numbers of HTL that could react to appropriate viral antigens. However, in several experiments PBMC from individuals who were seronegative for either virus also had detectable numbers of HTL that could react to appropriate viral antigens. When these data were examined more closely, the (16) . It should be noted that these authors monitored the proliferation of T cells rather than the production of TCGF as an index of HTL function in limitingdilution microcultures.
When the relationship between virus-reactive serologic status and viral antigen-reactive HTL frequency was examined in greater detail by using CMV and HSV, we observed that individuals who are seropositive for either virus have relatively high (comparable with alloantigen-reactive HTL) HSV antigen-reactive or CMV antigen-reactive HTL frequencies (Table 3 ). This was not unexpected, since we had previously observed that PBMC from seropositive individuals were efficient at producing lymphokines when cultured with appropriate viral antigens (8) . However, as found initially with HSV, CMV-reactive HTL could still be detected by LDA in PBMC populations from some CMVseronegative individuals (Table 3) . These latter frequencies appeared to be highly variable and ranged from undetectable to quite prominent, even within the same individual at different times.
Initially, HSV and CMV antigen reactivities were compared in these experiments to verify the viral antigen specificity of the HTL responses that were detected in the limiting-dilution microcultures. Because of the experimental results, further investigations are necessary to provide definitive data in this regard. Interestingly, murine studies utilizing LDA techniques (23) detected HTL that displayed patterns of cross-reactivity to influenza viral determinants that differed markedly from specificities determined by conventional culture systems (2) . Furthermore, recent studies using Western (immuno-) blot analysis and immunoprecipitation techniques reported on antigenic cross-reaction between proteins of human HSV, CMV, and Epstein-Barr virus (33) and between HSV and varicella-zoster virus (37) . This raises the possibility that cross-reactivity to herpesvirus proteins could be reflected by the HTL themselves, with the antigen specificity determined by antigen-specific regulatory cells that are more effective at high densities, as suggested by others (23) . However, whether such cross-reactivities could result in the highly variable HTL frequencies observed for seronegative individuals is not known.
Theoretically, there are a number of immunologic explanations for the seronegativity of a given individual for a particular virus. Ranging from simplest to most complex, these include (i) lack of prior exposure to viral antigens, (ii) lack of cellular ligands for viral binding and infection, (iii) lack of viral antigen-reactive B-cell clones, (iv) lack of viral antigen-reactive helper T-cell clones, and (v) presence of a virus-responsive regulatory mechanism which actively impairs the function of viral antigen-reactive B cells or HTL. Our data appear to eliminate the fourth possibility. The other possibilities require further investigation. Although the data concerning HTL in seropositive and seronegative individuals are not definitive, there is certainly enough information to warrant continued investigation in this area. Since these data could not have been obtained with conventional lymphocyte culture techniques, these experiments also illustrate the effectiveness and utility of LDA as a research tool for investigating some of the more subtle aspects of viral antigen-induced T-cell behavior.
